Who Can Use Ozempic for Weight Loss?

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, reduces appetite and blood sugar levels, making it effective for sustained weight loss in appropriate candidates. Not everyone qualifies for this medication, and understanding your eligibility is the first step toward choosing the right treatment path. PlexusDx evaluates your complete health picture to recommend whether semaglutide injections align with your weight loss goals.

BMI and Weight Loss Candidacy for Semaglutide

Your body mass index (BMI) is a starting point for semaglutide eligibility. Adults with a BMI of 27 or higher who also have weight-related health conditions—such as hypertension, type 2 diabetes, or elevated cholesterol—may be candidates for GLP-1 therapy. Those with a BMI of 30 or higher are generally considered for weight loss treatment regardless of other conditions.

However, BMI alone does not determine whether semaglutide is appropriate for you. Your metabolic health, medication history, and specific health challenges all influence whether this therapy will be safe and effective. PlexusDx reviews your individual clinical profile to confirm that semaglutide injections address your unique weight loss needs.

Medical Conditions That Support Semaglutide Use

Patients with type 2 diabetes, prediabetes, or metabolic syndrome often benefit from semaglutide's dual action on blood sugar and appetite regulation. Those with obesity-related conditions like sleep apnea, osteoarthritis, or cardiovascular risk factors are strong candidates because weight reduction directly improves these health markers.

Chronic conditions such as polycystic ovary syndrome (PCOS) and non-alcoholic fatty liver disease (NAFLD) may also warrant semaglutide consideration, as weight loss improvements correlate with disease progression slowing. Your complete medical history—including past surgeries, current medications, and family disease patterns—helps PlexusDx determine if semaglutide therapy is suitable for your situation.

Contraindications and Reasons You May Not Qualify

Semaglutide is not appropriate for people with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant or breastfeeding individuals should not use semaglutide, as safety data in these populations remains limited. Severe kidney or liver disease also raises safety concerns and typically excludes candidates from this therapy.

Certain medications interact with semaglutide, particularly insulin or other diabetes drugs that require dosage adjustment. A history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy complications may affect your eligibility. PlexusDx conducts a thorough medication and condition review to ensure semaglutide poses no contraindication risk.

How PlexusDx Determines Your Semaglutide Eligibility

PlexusDx begins with a detailed health questionnaire and review of your current medications, past medical history, and weight loss goals. A licensed clinician evaluates your eligibility based on established clinical guidelines, ensuring that semaglutide injections align with your health profile and expected outcomes.

For patients approved for treatment, PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan—a flat rate that means your dose can increase as needed without a price increase. An optional Precision Peptide Genetic Test ($298) maps 14 metabolic pathways and 49 peptide markers, revealing genetic predispositions that may influence how your body responds to GLP-1 therapy and inform dose titration decisions.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a diagnosis of diabetes to use semaglutide through PlexusDx?

No. Semaglutide is approved for weight loss in adults with a BMI of 27 or higher who have at least one weight-related condition, or a BMI of 30 or higher regardless of other conditions. PlexusDx evaluates eligibility based on your complete health profile, not diabetes status alone.

What clinical evidence supports semaglutide for weight loss?

The STEP trials demonstrated that adults on semaglutide lost 10–22% of their body weight over 68 weeks, compared to 2–3% in placebo groups. Long-term data shows sustained weight loss and improvements in cardiovascular risk factors, blood pressure, and metabolic markers.

How much does PlexusDx compounded semaglutide cost?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain flat regardless of your dose level—your dose may increase as needed, but your price won't. No insurance is required, and treatment is HSA/FSA eligible.

Are there any serious side effects that would make me ineligible?

Most people tolerate semaglutide well, with common mild side effects including nausea and gastrointestinal changes that typically diminish over time. However, a history of pancreatitis, medullary thyroid cancer, or MEN2 syndrome excludes you from treatment. PlexusDx assesses your risk profile before approval.

How can the PlexusDx Precision Peptide Genetic Test help my treatment?

The Precision Peptide Genetic Test analyzes key variants (GIPR rs1800437, FTO rs9939609, MC4R rs17782313) across 14 metabolic pathways to reveal how your genetics influence appetite regulation and peptide response. This insight helps guide your semaglutide dose and treatment strategy.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.